ANIP icon

ANI Pharmaceuticals

101 hedge funds and large institutions have $317M invested in ANI Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 30 increasing their positions, 22 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
101
Holders Change
+29
Holders Change %
+40.28%
% of All Funds
2.7%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
43
Increased
30
Reduced
22
Closed
12
Calls
$672K
Puts
$118K
Net Calls
+$554K
Net Calls Change
+$554K
Name Holding Trade Value Shares
Change
Shares
Change %
DM
101
Deerfield Management
New York
-$17.2M -607,355 Closed
HVC
102
Healthcare Value Capital
New Jersey
-$9.9M -350,000 Closed
PCM
103
Penn Capital Management
Pennsylvania
-$4.05M -143,220 Closed
EA
104
Emerald Advisers
Pennsylvania
-$3.27M -115,440 Closed
EMFAT
105
Emerald Mutual Fund Advisers Trust
Pennsylvania
-$2.95M -104,134 Closed
CCMH
106
Cornerstone Capital Management Holdings
New York
-$651K -23,000 Closed
Jane Street
107
Jane Street
New York
-$399K -14,096 Closed
VKH
108
Virtu KCG Holdings
New York
-$315K -11,156 Closed
AL
109
Airain Ltd
Guernsey
-$269K -9,521 Closed
WA
110
WFG Advisors
Texas
-$28K -1,000 Closed
SFU
111
Stonehage Fleming (UK)
United Kingdom
-$12K -413 Closed
BNP Paribas Financial Markets
112
BNP Paribas Financial Markets
France
-$3.2K -113 Closed